103
Participants
Start Date
November 6, 2012
Primary Completion Date
March 15, 2013
Study Completion Date
January 24, 2014
Velpatasvir
Tablets administered orally
Placebo
Tablets administered orally
CRI Worldwide, LLC, Philadelphia
Avail Clinical Research, LLC, DeLand
Orlando Clinical Research Center, Orlando
New Orleans Center for Clinical Research-Knoxville, Knoxville
Kansas City Gastroenterology and Hepatology, Kansas City
Alamo Medical Research, San Antonio
West Coast Clinical Trials, LLC, Costa Mesa
Charles River Clinical Services Northwest, Inc., Tacoma
CRI Worldwide, LLC, Marlton
Fundacion De Investigacion De Diego, San Juan
Lead Sponsor
Gilead Sciences
INDUSTRY